ATM and urinary bladder carcinoma: According to their ATM gene mutation status, bladder cancer patients with mutation data treated with ICIs (anti-pd-1/pd-l1 therapies) (n = 210) were divided into ATM-MT and ATM-WT groups, and then KM analysis was performed.